|
|
| 14 Oct 2026 | 14:10 IST |
|
HDFC Pharma and Healthcare Fund - Direct (IDCW) |
|
|
|
|
|
|
|
| NAV Details |
| NAV Date : |
13-Oct-26 |
| NAV [Rs]: |
21.50 |
| Buy/Resale Price [Rs] : |
0.00 |
| Sell/Repurchase Price [Rs] : |
0.00 |
| Max Entry Load % : |
0.00 |
| Max Exit Load % : |
0.00 |
|
|
|
|
|
|
|
|
| Quantum of Dividend % |
NA |
NA |
| Date |
NA |
NA |
|
|
|
|
|
|
| Tax benefits : |
|
| Min. Investment(Rs.) : |
100 |
| Increm.Investment(Rs.) : |
100 |
|
|
|
|
|
| Statistical Ratios |
What
is Beta ?
Beta is a measure of the volatility of the portfolio to that of the index. In
simple words it shows the movement of the portfolio in comparison. The Higher
the Beta, higher the volatility of the scheme to the index. If its greater
than1 , then the portfolio is highly volatile to the movemnts in the index. If
the beta is lesser than 1 , then scheme is less volatile to the index and beta
which is close to 1 implies that the scheme is closely following the index.
|
| 0.6737 |
4.7053 |
1.4646 |
23.7576 |
0.1571 |
|
|
|
|
Divi's Lab.
|
9.39
|
|
Sun Pharma.Inds.
|
8.28
|
|
Alkem Lab
|
4.64
|
|
Cipla
|
4.15
|
|
Apollo Hospitals
|
3.69
|
|
Torrent Pharma.
|
3.65
|
|
Max Healthcare
|
3.61
|
|
Aster DM Quality
|
3.56
|
|
Lupin
|
3.55
|
|
Neuland Labs.
|
3.24
|
|
Shilpa Medicare
|
3.23
|
|
Dr Reddy's Labs
|
3.19
|
|
Acutaas Chemical
|
3.18
|
|
Anthem Bioscienc
|
3.17
|
|
Ipca Labs.
|
2.98
|
|
Global Health
|
2.72
|
|
Rubicon Research
|
2.52
|
|
Krishna Institu.
|
2.10
|
|
Glenmark Pharma.
|
2.09
|
|
Molbio Diagnosti
|
2.01
|
|
Vijaya Diagnost.
|
2.00
|
|
Zydus Lifesci.
|
1.82
|
|
Gland Pharma
|
1.78
|
|
Wockhardt
|
1.71
|
|
Jupiter Life Lin
|
1.68
|
|
Metropolis Healt
|
1.67
|
|
Sai Life
|
1.58
|
|
Biocon
|
1.47
|
|
Symbiotec Pharma
|
1.36
|
|
Thyrocare Tech.
|
1.10
|
|
Corona Remedies
|
1.04
|
|
Entero Healthcar
|
1.01
|
|
Jubilant Pharmo
|
0.93
|
|
ERIS Lifescience
|
0.92
|
|
Novartis India
|
0.55
|
|
Bajaj Healthcare
|
0.53
|
|
Laxmi Dental
|
0.35
|
|
Cohance Life
|
0.32
|
|
TREPS
|
4.67
|
|
Net CA & Others
|
-1.44
|
|
|
|
|
|
|
Asset Allocation
|
|
|
|
 |
|